Lékařská fakulta, Masarykova Univerzita

Metzler M, Wilda M, Busch K, et al. Genes Chromosomes Cancer 2004, 39: 167

Meyers MA. Neoplasms of the digestiva tract: imaging, staging, and management. 1st ed. Philadelphia:Lippincot Raven, 1998, Dodd GD, Soulen MC, Kane RA, et al. Minimally invasive treatment of malignant hepatic tumors: at the threashold of a major breakthrough. Radio Graphics 2000, 20, 9-27

Michael MZ, O´Connor SM, van Holst Pellekaan NG, et al. Mol. Cancer Res. 2003, 1: 882.

Michaelis, L. C. & Ratain, M. J. Measuring response in a post-RECIST world: from black and white to shades of grey. Nature Rev. Cancer 2006, 6, 409–414

Miller FH, Keppek AL, Reddy D, et al. Response of liver metastases after treatment with Yttrium-90 microspheres: Role of size, necrosis and PET. AJR 2007, 188: 776-83

Minagawa M, Yamamoto J, Kosuge T et al. Simplified staging systém for predictingthe prognosis of patients with resectable liver metastases. Arch Surg 2007,142:269-76

Moffat, B. A. et al. Functional diffusion map: A noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc. Natl Acad. Sci. USA 2005, 102, 5524–5529.

Monsky WL, Kruskal JB, Lukyanov AN et al. Radiofrequency ablation increases intratumoral liposomal doxorubicin accumulation in a rat breast tumor model. Radiology 2002, 224: 823-9.

Mulier S, Ni Y, Jamart J, et al. Local recurrence after hepatic radiofrequency coagulation:multivariate meta-analysis and review of contributing factors. Ann Surg 2005, 242: 158-71

Muller H, Nakchbandi W, Chatzissavvidis I, et al. Intra-arterial infusion of 5-fluorouracil plus granulocyte-macrophage colony stimulating factor (GM-CSF) and chemoembolisation with melphalan in the treatment of disseminated colorectal liver metastases. European Journal of Surgical Oncology. 2001, 27: 652-61.

Munn, D. H. & Mellor, A. L. Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J. Clin. Invest. 2007, 117, 1147–1154.

Munzarova M : Genetic susceptibility to malignant diseases – ethical issues. Minireview. Neoplasma 2002, 49(1): 1-4,

Munzenrider JE, Liebsch NJ. Proton therapy for tumors of the skull base. Strahlenther Onkol. 1999;175(suppl 2):57-63

Nakano I, Kornblum HI. Pediatr Res 2006, 59: 54R-58R

Navarra G, Ayav A, Weber JC, et al.: Short- and-long term results of intraoperative radiofrequency ablation of liver metastases. Int J Colorectal Dis 2005;20:521–528.

Nemati F, Dubernet C, Fessi H, et al. Reversion of multidrug resistance using nanoparticles in vitro: influence of the nature of the polymer. Int. J. Pharm. 1996,138: 237–246

Neves, A. A. et al. A paramagnetic nanoprobe to detect tumor cell death using magnetic resonance imaging. Nano Lett. 2007, 7, 1419–1423

Nishi S, Shindo M, Abe J. Clinical aspects of indocyanine green pharmacokinetics following portal vein administration Br J Clin Pharacol 1998; 45:41-47

Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases of the liver. Cancer 1996, 77: 1254-62,

Ntziachristos, V., Yodh, A. G., Schnall, M. & Chance, B. Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. Proc. Natl Acad. Sci. USA 2000, 97, 2767–2772.

O´Brien CA et al. A Human colon cancer cell capable of initiating tumour groeth in immunodeficient mice. Nature 2007, 445: 106-110.

Ogata S, Belghiti J, Farges O, et al. Sequential arterial and portal vein embolozations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma. Br.J.Surg 2006, 93: 1091-8

Oliver TG, Wechsler-Reya RJ. Neuron 2004, 42: 885-8

Oshowo A, Gillams A, Harrison E, et al. Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br.J Surg 2003, 90: 1240-43

Oxford Biomedica presents encouraging final phase II results with TROVAX® in colorectal cancer at the International Colorectal Cancer Congress. http://www.oxfordbiomedica.co.uk/news/2005-ob-31.htm

PACCE: Panitumumab advanced colorectal cancer evaluation study. Available at: http://clinicaltrials.gov/ct/show/NCT00115765?order=1) nebo (Intergroup CALGB 80405. http://www.cancer.gov/search/ResultsClinicalTrialsAdvanced.aspx?protocolsearchid=2851539

Pantarotto D, Partidos CD, Hoebeke J, et al. Immunization with peptide-functionalized carbon nanotubes enhances virus-specific neutralizing antibody responses. Chem Biol. 2003;10:961–966.

Pantarotto D, Briand J-P, Prato M, Bianco A. Translocation of bioactive peptides across cell membranes by carbon nanotubes. Chem Commun (Camb). 2004;16–17.

Pastorin G, Wu W, Wieckowski S et al. Double functionalization of carbon nanotubes for multimodal drug delivery. Chem Commun (Camb). 2006;1182–1184.

Pawlik TM, Izzo F, Cohen DS, et al. Combined resection and radiofrequency ablation of for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol 2003, 10: 1059-69

Pellot-Barakat C, Sridhar M, Lindfors KK, Insana MF. Ultrasonic elasticity imaging as a tool for breast cancer diagnosis and research. Curr. Med. Imaging Rev. 2006, 2, 157–164.

Petrovsky A, Schellenberger E, Josephson L, et al. Near-infrared fluorescent imaging of tumor apoptosis. Cancer Res. 2003, 63, 1936–1942

Phan, G. Q. et al. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc. Natl Acad. Sci. USA 2003, 100, 8372–8377

Poptani, H. et al. Detecting early response to cyclophosphamide treatment of RIF-1 tumors using selective multiple quantum spectroscopy (SelMQC) and dynamic contrast enhanced imaging. NMR Biomed. 2003, 16, 102–111

Pospíšilová Š, Brázda V, Kuchaříková K, et al. Activation of the DNA binding ability of latent p53 protein by proteinkinase C is abolished by proteinkinase CK2. Biochem J 2004, 378: 939-47

Raj GV, Moreno JG, Gomella LG.: Utilization of Polymerase chain reaction technology in the detection of solid tumors. Cancer (Phila.) 1998, 82: 1419-42

Rau HG, E. Buttler, G. Meyer, H.M. Schardey and F.W. Schildberg, Laparoscopic liver resection compared with conventional partial hepatectomy—a prospective analysis. Hepatogastroenterology 45 (1998), pp. 2333–2338.

Reilly RM, Kiarash R, Cameron RG, et al. 111In-Labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR. J Nucl. Med. 2000;41:429–438.

Reilly RM. Carbon nanotubes: potential Benefits and Risks of Nanotechnology in Nuclear Medicine. The journl of Nulear Medicine 2007, JUL, 48/7, 1039-42

Rengucci C, Maiolo P, Saragoni L et al.: Multiple detection of Genetic alterations in tumors and stool. ClinCancer res 2001, 7: 590-93

Rhim H, Yoon KH, Lee JM, et al. Major complications after radiofrequency thermal ablation of hepatic tumors: spectrum of imaging findings. RadioGraphics 2003, 23: 123-36

Rhim H, Dodd GD 3rd, Chintapalli KN, et al. Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications. Radiographicsnm2004, 24: 41-5

Ribero D, Abdala EK, Madoff DC, et al. portal vein embolization before majore hepatecomy and its effects on regeneration, resectability and outcome. Br J Surg 2008, in press

Ricci-Vittiani L et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445: 111-115

Rossi S, Garbagnati F, Lencioni R, et al. Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 2000, 217: 119-26

Rubbia-Brandt L, Audard V, Sartoretti P, et al: Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 2004, 15:460-466

Rubbia-Brandt LR, Tumor edge post chemotherapy. Annual Course in HPB Surgery and transplantation. 8th-10th Oct. 2007, Hammersmith Conference Centre, London

Sadelain M. Insertional oncogenesis in gene therapy: how much of a risk? Gene Ther 2004; 11: 569-573

Sakamoto I, Aso N, Nagaoki K, et al. Complications associated with transcatheter arterial embolization for hepatic tumors. RadioGraphics 1998; 18:605-619.

Saltz, I.B., Cox, J.V., Blanke, C., Rosen, L.S., Fehrenbacher, L., Moore, M.J: Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer . Irinotecan study group. N.Engl.J.Med., 2000, 343, 905-914

Saltz L, Lenz H, Kindler HL, et al. Interim report of randomized phase II trial of cetuximab/bevacizumab/irinotecan (CBI) versus cetuximab/bevacizumab (CB) in irinotecan-refractory colorectal cancer. Program and abstracts of the American Society of Clinical Oncology 2005 Gastrointestinal Cancers Symposium; January 27-29, 2005; Hollywood, Florida. Abstract 169b.

Salvador-Morales C, Townsend P, Flahaut E, et al. Carbon 2007, 45:607-17.

Salvador-Morales C, Basiuk EV, Basiuk AV, et l. J.Nanosci.Nanotechnol. 2007, was in press.

Sarantou T, Bilchik A, Ramming KP. Complications of hepatic cryosurgery. Semin Surg Oncol 1998;14:156–162.

Sato K, Lewandowski RJ Nui JT, et al. Treatment of inresectable primary and metastatic liver cancers with yttrium-90 microspheres (Therasphere): assessment of the hepatic arterial embolization. Cardiovasc Intervent Radiol 2006, 29:522-29

Sauer R, Becker H, HohenbergerWet al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731–1740.

Seifert JK, Morris DL. World survey on the complications of hepatic and prostate cryotherapy. World J Surg 1999;23:113–114.

Seki T, Wakabayashi M, Nakagawa T, et al. Ultrasonically guided persutanous microwave coagulation therapy for small hepatocellular carcinoma. Cancer 1994, 74: 817-25.

Seregni E, Ferrari L, Martinetti A, Bombardieri E : Diagnostic and prognostic tumor markers in the gastrointestinal tract. Semin Surg Oncol. 2001, 20(2): 147-66

Shaw IM, Rees M, Welsh FK, Bygrave S, John TG. Repeat hepatic resection for recurrent colorectal liver metastases is associated with favourable longterm survival. Br J Surg. 2006;93(4):457-464.

Shibata T, Niinobu T, Ogata N, Takami M. Mocrowave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Cancer 2000, 89(2): 276-84

Shipley WU, Verhey LJ, Munzenrider JE, et al. Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int J Radiat Oncol Biol Phys. 1995;32:3-12

Shirabe K, Shimada M, Gion T, et al. Postoperative liver failure after major hepatic resection or hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg 1999, 188: 304-9

Schell SR, Wessels FJ, Abouhamze a, et al. Pro- and anti-inflamatory cytokine Production after Radiofrequency Ablation of Unresectable Hepatic Tumors. J Am Coll Surg 2002, 195: 774-81

Schellenberger, E. A. et al. Annexin V-CLIO: a nanoparticle for detecting apoptosis by MRI. Mol. Imaging 2002, 1, 102–107.

Scherer LJ, Rossi JJ. Natur. Biotechnol. 2003, 12: 1457.

Schoenthaler R, Castro JR, Petti PL, et al. Charged particle irradiation of sacral chordomas. Int J Radiat Oncol Biol Phys. 1993;26:291-298

von Schulthess, G. K., Steinert, H. C. & Hany, T. F. Integrated PET/CT: Current applications and future directions. Radiology 2006, 238, 405–422.

Salem R, Lewandowski RJ, Atassi B, et al. Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response and suvival. J Vasc Interv Radiol 2005, 16: 1627-1639

Schulz-Ertner D, Nikoghosyan A, Thilmann C, et al. Results of carbon ion radiotherapy in 152 patients. Int J Radiat Oncol Biol Phys. 2004;58:631-640

Simillis C, Constantinides VA, Tekkis PP, et al. Laparoscopic versus open hepatic resections for benign and malignant neoplasms – a meta-analysis. Surgery. 2007, 141 (2): 203-11.

Singh SK et al. Identification of a Cancer Stem Cell in Human Brain Tumors. Cancer Res 2003, 63: 5821-5828.,

Singh SK et al. Identification of human brain tumour initiating cells. Naure 2004, 432: 396-401,

Singh SK et al. 2004, Oncogene 23: 7267-73

Siperstein A, Garland A, Engle K et al. Local recurrence after laparoscopic radiorequency thermal ablation of hepatic tumors. Ann Surg Oncol. 2007, 7: 106-113.

Sipkins, D. A. et al. Detection of tumour angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging. Nature Med. 1998, 4, 623–626

SIRTEX Medicl: EC-SIR-SPHERES. User´s manual.

Sitharaman B, Kissell KR, Hartman KB, et al. Superparamagnetic gadonanotubes are high-performance MRI contrast agents. Chem Commun (Camb). 2005;3915–3917.

Skřivanová K, Škorpíková J, Švihálek J, et al. Photochemical properties of a potential photosensitiser indocyanine green in vitro. Journal of Photochemistry and Photobiology B:Biology 2006, 85: 150-154

Smith AM, Shelton RM, Harris JJ, Perrie Y. J-Pharm.Pharmacol. 2005, 57: 42.

Smith AM, et al. Photoactive liposomes in tissue ingeneering. presented at the New frontiers in nanomeicine, London Hammersmith Hospital Conmference, October 16, 2007.

Smith GL, Zagha RM, Libertino JA. Description of Technique and Initial Results: The Habib 4X Bipolar resection Device in Open Nephron Sparing Surgery Without Renal Artery Occlusion. Lahey Clinic Abstract 2007, Burlington Massachusetts

Solbiati L, Goldberg SN, Ierace T, et al. Hepatic metastases: percutaneous radio-frequency ablation with cooled tip electrodes. Radology 1997, 205: 367-73

Sorensen SM, Mortenses FV, Nielsen DT. Radiofreqiency ablation of colorectal liver metastases: long-term survival. Acta Radiol 2007, 48: 253-8

van Steenis JH, van Maarseveen EM, Verbaan FJ, et al. Preparation and characterization of folate-targeted pEG-coated pDMAEMA-based polyplexes. J Control Release 2003; 87: 167-176

Stevenson, FK, Rice, J, Ottensmeier, CH, Thirdborough, SM and Zhu, D (2004). DNA fusion gene vaccines against cancer: from the laboratory to the clinic. Immunol Rev 199: 156–180.

Stewart GJ, Preketes A, Horton M, et al. Hepatic cryotherapy: double-freeze cycles achieve greater hepatocellular injury in man. Cryobiology 1995;32:215–219.

Stone MD, Cady B, Jenkins RL, et al. Surgical therapy for recurrent liver metastases from colorectal cancer. Arch Surg 1990, 125: 718

Stubbs RS, Cannan RJ, Mitchell AW. Selective internal radiation therapy with 90yttrium microspheres for extensive colorectal liver metastases. J gastrointest Surg 2001, 5: 292-302.

Su, H. et al. Monitoring tumor glucose utilization by positron emission tomography for the prediction of treatment response to epidermal growth factor receptor kinase inhibitors. Clin. Cancer Res. 2006, 12, 5659–5667

Subar DA, Sheen AJ, Sherlock DJ, et al. Cryoablation of liver tumors – is there clinical utility? Med Gen Med 2003, 7: 5-19

Sudheendra D, Neeman Z, Kam A, et al. Intermittent hepatic vein baloon occlusion during radiofrequency ablation of the liver. Cardiovasc Interv Radiology 2006, 29: 1088-92.

Sullivan RD, Nercross JW, Watkins E jr. Chemotherapy of metastatic liver cancer by prolonged hepatic-artery infusion. N Engl J Med 1964, 270: 321-7

Suzuki, Inaba, Yokoi, Ohata, Ota, Photodynamic therapy for malignant biliary obstruction : a cas series, Endoscopy 2004, 36: 83-7

Sweeney RA, Vogele M, Wegmazr A, Lukas P, Auberger T. The patient positioning concept for the planned MedAustron centre.Radiother. Oncol. 2004; 73Suppl 2: 64-7

Szebeni J, Baranyi L, Savay S, et al. Role of complement activation in hypersenzitivity reactions to Doxil and Hynic PEG liposomes: Experimental and cilinical studies. Journal of Liposome Research, 2002, 12:1, 165 – 172

Szebeni J, et al. Mechanisms and approaches for the prevention of adverse immune reactions to nanomedicines. presented at New frontiers in nanomedicine, Hammersmith Hospital Conference Centre, London October 2007

Šachlová M, Foretová L : Intestinal polyposis syndrome and the genetics of colorectal carcinoma. Klin Onkol., 11: 107-12, 1998

Takagi S, Hepatic and portal vein blood flow during carbondioxide pneumoperitoneum for laparoscopic hepatectomy. Surg Endosc 12 (1998), pp. 427–431.

Takahashi Y, Teshima T, Kawaguchi N, et al. Heavy ion irradiation inhibits in vitro angiogenesis even at sublethal dose. Cancer Res.  2003; 63(14):4253-7

Takamizawa J, Konishi H, Yanagisawa K, et.al. Cancer Res. 2004, 64: 3753.

Tam W, Ben-Yehuda D, Hayward WS Mol. Cell. Biol. 1997, 17: 1490

Tanaka K, Shimada H, Matsuo K et al. Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases. Surgery 2004;136:650–659.

Taylor MD et al. 2005, Cancer Cell 8: 323-335

Terraz S, Constantin Ch, Majno P, et al. Image-guided multipolar radiofrequency ablation of liver tumours: initial clinical results. Eur Radiol 2007, 21

Therasse, P. et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J. Natl Cancer Inst. 2000, 92, 205–216.

Thirion P, Michielis S, Pignogn, et al. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an update meta-analysis. The Meta-Analysis Group In Cancer. J.Clin Oncol 2004, 22: 3766-3775.

Tisman G, MacDonald D, Shindell N, et al. Oxaliplatin Toxicity Masquerading As Recent Colon Cancer. J Clin Oncol 2004, : 3202-4

Tono T, Hasuike Y, Ohzato H, Takatsuka Y, Kikkawa N. Limited but definitive efficacy of prophylactic hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases: A randomized study. Cancer 2000, 88: 1549-1556

G. Torzilli, P. Leoni, A. Gendarini, F. Calliada, N. Olivari and M. Makuuchi, Ultrasound-guided liver resections for hepatocellular carcinoma. Hepatogastroenterology 49 43 (2002), pp. 21–27.

Tournigand C, Andre T, Achille E, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 2004, 22: 229-237

Treupel L, Poupon MF, Couvreur P, Puisieux P. Vectorisation of doxorubicin in nanospheres and reversion of pleiotropic resistance of tumor cells. C. R. Acad. Sci. 1991, III 313/17 : 1–174.

Uziely B, Jeffers S, Isacson R, et al. Liposomal Doxorubicin: Antitumor Activity and Unique Toxicities During two Complementary Phase I Studies. J. Clin. Oncol. 1995, 13, 1777–1785.

Válek V.: Maligní obstrukce žlučových cest: 5 let zkušeností s léčbou Wallstentem a brachyterapií- prospektivní randomizovaná studie. Čes. Radiol. 2000, 54, (2): 92 – 96

Válek V, Kala Z, Kiss I, et al. Maligní ložiskové procesy jater. Diagnostika a léčba včetně minimálně invazivnívh metod. 1. vyd., Praha 2006, Grada Publishing.

Válek V, KyselaP, Kala Z, et al. Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: a prospective randomised study. European journal of radiology, 2007, 62, 2: 175-9

Van den Berg A, Kroesen BJ, Kooistra K, et al. Genes Chromosomes Cancer 2003, 37: 20.

Van Hazel G, Blackwell A, Anderson J, et al. Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy vs fluorouracil/leucovorin hemotherapy alone in advanced colorectal cancer. J Surg Oncol 2004, 88: 78-85

Vauthey JN, Chaoui A, Do KA, et al. Standardozed measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 2000, 127: 512-19

Vauthey JN, Abdalla EK, Doherty DA, et al. Body surface area and body weight predict total liver volume in western adults. Liver Transpl. 2002, 8: 233-40,

Vauthey JN, Pawlik TM, Ribero D, et al. Chemotherapy regimen predicts steatohepatitis and increase in ninety-day mortality after surgery for hepatic colorectal metastasis. J Clin Oncol 2006, 2004: 2065-72

de Verdière AC, C. Dubernet, et al. Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action. Br. J. Cancer 1997, 76: 198–205.

Verdun C, Brasseur F, Vranckx H, Couvreur P, Roland M. Tissue distribution of doxorubicin associated with polyhexylcyanoacrylate nanoparticles. Cancer Chemother. Pharmacol. 1990, 26: 13–18.

Vogl TJ, Straub R, Eichler K, et al. Malignant liver tumors treated with MR imaging-guided laser-inducet thermotherapy experience with complications in 899 patients (2.520 lesions). Radiology 2002, 225: 367-77

Vogl TJ, Straub R, Eichler K, et al. Colorectal carcinoma metastasis in liver: Laser-induced Interstitial Thermotherapy – Lol tumor control rate and survival data. Radiology 2004, 230: 450-458.

Voorhees PM, Dees EC, O'Neil B, Orlowski RZ. The proteasome as a target for cancer therapy. Clin. Cancer Res. 2003, 9 (17): 6316-25.

Washington K, Debelak JP, Gobbell C, et al. Hepatic cryoablation-induced acute lung injury. Histopathologic findings. J Surg Res 2001;95:1–7.

Wang Y, Schulte BA, Larue AC, Ogawa M, Zhou D. Total body irradiation selectively induces murine hematopoietic stem cell senescence. Blood 2006;107:358-66

Weber JC, Navarra G, Jiao LR, et al.: New technique for liver resectionusing heat coagulative necrosis. Ann Surg 2002;236: 560–563.

Weber JC, Bachellier P, Oussoultzoglou E et al. Simultaneous resection of colorectal primary tumour and synchronous liver metastases. Br J Surg 2003; 90: 956 –962.

Weber WA. Positron emission tomography as an imaging biomarker. J. Clin. Oncol. 2006, 24, 3282–3292.

Weissleder, R., Tung, C.-H., Mahmood, U. & Bogdanov, A. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nature Biotech. 1999, 17, 375–378.

Wieder H, et al. PET imaging with [11C]methyll-methionine for therapy monitoring in patients with rectal cancer. Eur. J. Nuc. Med. Mol. Imaging 2002, 29, 789–796.

Wicha MS, et al. Cancer Res 2006, 66: 1883-90

Wilson RR. Radiological uses of fast protons. Radiology. 1946;47: 487-491.

Winter, P. M. et al. Molecular imaging of angiogenesis in nascent vx-2 rabbit tumors using a novel αvβ3-targeted nanoparticle and 1.5 Tesla magnetic resonance imaging. Cancer Res. 2003, 63, 5838–5843

Wong CO, Savin M, Sherpa KM, et al. Regional yttrium-90 microsphere treatment of surgically unresectable and chemotherapy refractory metastatic liver carcinoma. Cancer Biother Radiopharm 2006, 21: 305-13

Wood TF, Rose DM, Chung M, et al. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Annals of Surgical Oncology 2000, 7(8):593-600

Woodword-Richens K, Bevan S, Churchman M: Analysis fo genotypic and phenotypis heterogenity in juvenile polyps. Gut, 46(5): 656-60, 20

Wrightson WR, M.J. Edwards and K.M. McMasters, The role of the ultrasonically activated shears and vascular cutting stapler in hepatic resection. Am Surg 66 (2000), pp. 1037–1040.

Yoon CHJ, Chung JW, Park JH. Transcatheter arterial chemoemboliyation with paclitaxel-lipiodol solution in rabbit VX2 liver tumor. Radiology 2003, 229, 126-131

Yoshimoto, M. et al. Characterization of acetate metabolism in tumor cells in relation to cell proliferation: Acetate metabolism in tumor cells. Nucl. Med. Biol. 2001, 28, 117–122.

Yun, S. H. et al. Comprehensive volumetric optical microscopy in vivo. Nature Med. 2006, 12, 1429–1433.

Zacharoulis D, Asopa V, Navarra G, et al.: Hepatectomy using intraoperative ultrasound-guided radiofrequency ablation. Int Surg 2003;88:80–82.

Zhang JS, Liu F, Huang L. Implications of pharmacokinetic behavior of lipoplex for its inflammatory toxicity. Adv Drug Deliv Rev 2005; 57: 689-698

Zhao, M., Beauregard, D. A., Loizou, L., Davletov, B. & Brindle, K. M. Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nature Med. 2001, 7, 1241–1244.

Zhu, D. & Stevenson, F. K. DNA gene fusion vaccines against cancer. Curr. Opin. Mol. Ther. 2002 4, 41–48.

Zorko M, Langel U. Cell-penetrating peptides: mechanism and kinetics of cargo delivery. Adv Drug Deliv Rev 2005; 57: 529-545